drugset / Trial / NCT06311760
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 In Healthy Participants
RandomizedSequentialDouble-blindOther
Summary
This study will assess the safety, tolerability and pharmacokinetics (PK) of AZD0292 following intravenous (IV) administration of single ascending doses to healthy adult participants.
Timeline
- Start
- 2024-04-09
- Primary completion
- 2025-02-20
- Completion
- 2025-02-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD0292 | Monoclonal antibody | — | Intravenous |
Indications
No indication recorded.